Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
批准号:
8438137
负责人:
Kathleen Mulligan
金额:
$62.36万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-06-01 至 2018-05-31
关键词:
AdherenceAffectApolipoproteinsApolipoproteins BCarbohydratesCardiovascular DiseasesChylomicronsConsumptionCrossover DesignDataDietDiet FadsDietary FatsDietary SugarsDual-Energy X-Ray AbsorptiometryDyslipidemiasEvidence based interventionFastingFatty acid glycerol estersFrequenciesFructoseHealth PolicyHepaticHigh Density LipoproteinsHigh Pressure Liquid ChromatographyHousingHyperlipidemiaImageIndividualIngestionIntakeIntestinesKineticsLeadLinkLipidsLipoproteinsLiverLiver diseasesLow-Density LipoproteinsMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMeasuresMetabolicMetabolic Clearance RateMetabolismMethodsMinorModelingNutrientObesityOutcome StudyOverweightParticipantParticle SizePatternPhysiologicalPlasmaPopulationProductionPublic HealthRandomizedRecommendationRiskRisk FactorsRoleSerumSourceSucroseTechniquesTestingTimeTracerTriglyceridesVery low density lipoproteinVisceralWeightapolipoprotein B-48basecardiovascular disorder riskenergy balanceevidence basefeedinggel electrophoresislipid biosynthesislipoprotein triglyceridemathematical modelmetabolic abnormality assessmentnon-alcoholic fatty livernovelparticlepublic health relevanceresponsestable isotopesugartranslational studyvery low density lipoprotein triglyceridevolunteerward
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The past few decades heralded an era of high carbohydrate (CHO) diets, some of which are now known to worsen lipid profiles and increase risk of cardiovascular disease (CVD). Both diet composition and meal frequency affect lipid synthesis and kinetics, but the specific mechanisms remain unsettled. We will test the hypothesis that the conversion of CHO to fat (de novo lipogenesis [DNL]) is a major determinant of postprandial triglyceride (TG) and lipoprotein fluxes leading to higher levels of serum TG and dyslipidemia. We propose to perform controlled metabolic studies that use diet composition and meal frequency to modulate postprandial DNL and assess its impact on TG and apolipoprotein (apo) B fluxes, lipid profiles and lipoprotein particle distribution. We will do so by measuring th individual contributions of very low density lipoprotein (VLDL; from the liver) and chylomicrons (chylos, from the intestine) to overall postprandial lipoprotein-TG production and clearance in overweight and obese volunteers, a population that is at risk for CVD. We will compare the effects of 7 days feeding with two isocaloric diets (randomly assigned) that are either high in sucrose or high in fat on postprandial DNL, VLDL-TG and chylo-TG, and apolipoprotein B100 and B48 fluxes using stable isotope tracers and sophisticated mathematical modeling. Using a randomized crossover design in participants assigned to each diet, we will also compare the magnitude of differences between successive 7-day periods of consuming small frequent meals (nibbling) and ingesting 2 daily meals, with each participant serving as his/her own control. Participants will be housed in a metabolic ward and fed constant weight-maintaining diets to assure dietary adherence and control activity. Liver lipid storage will be measured by magnetic resonance (MR) spectroscopy, visceral fat by MR imaging, and lean and fat mass by dual energy X-ray absorptiometry. To further link the dynamic fluxes to atherogenic risk, the composition of VLDL and chylo remnants, lipoprotein particle sizes, small dense low density lipoprotein and high density lipoprotein will be measured using proprietary HPLC methods and gel electrophoresis. We anticipate that these novel studies will allow us to identify, for the firs time, the mechanisms by which meal composition and frequency affect postprandial apoB and TG fluxes and associated lipid profiles. These findings could inform efforts to develop evidence-based interventions and dietary guidance to mitigate CVD risk.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
-
批准号:9069958
-
项目类别:
-
资助金额:$61.32万
-
财政年份:2013
-
负责人:Kathleen Mulligan
-
依托单位:
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
-
批准号:9294153
-
项目类别:
-
资助金额:$61.68万
-
财政年份:2013
-
负责人:Kathleen Mulligan
-
依托单位:
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
-
批准号:8666804
-
项目类别:
-
资助金额:$60.44万
-
财政年份:2013
-
负责人:Kathleen Mulligan
-
依托单位:
VIRAL BURDEN, ALTERED METABOLISM, AND HIV WASTING
-
批准号:7203003
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2004
-
负责人:Kathleen Mulligan
-
依托单位:
METABOLIC EFFECTS OF PROTEASE INHIBITORS IN HIV DISEASE
-
批准号:7203006
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2004
-
负责人:Kathleen Mulligan
-
依托单位:
Viral burden, altered metabolism, and HIV wasting
-
批准号:7044899
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2003
-
负责人:Kathleen Mulligan
-
依托单位:
METABOLIC EFFECTS OF PROTEASE INHIBITORS IN HIV DISEASE
-
批准号:7044902
-
项目类别:
-
资助金额:$1.31万
-
财政年份:2003
-
负责人:Kathleen Mulligan
-
依托单位:
INHIBITION OF CYTOKINE PRODUCTION/VIRAL REPLICATION ON BODY COMPOSITION
-
批准号:6305597
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1999
-
负责人:Kathleen Mulligan
-
依托单位:
NANDROLONE IN HIV ASSOCIATED WEIGHT LOSS
-
批准号:6305594
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1999
-
负责人:Kathleen Mulligan
-
依托单位:
ACTG 329: NANDROLONE DECANOATE IN WOMEN W/ HIV ASSOCIATED WEIGHT LOSS
-
批准号:6305553
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1999
-
负责人:Kathleen Mulligan
-
依托单位:
ACTG 329: NANDROLONE DECANOATE IN WOMEN W/ HIV ASSOCIATED WEIGHT LOSS
-
批准号:6264517
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:Kathleen Mulligan
-
依托单位:
METABOLIC EFFECTS OF PROTEASE INHIBITORS IN HIV DISEASE
-
批准号:6523737
-
项目类别:
-
资助金额:$25.75万
-
财政年份:1998
-
负责人:Kathleen Mulligan
-
依托单位:
INHIBITION OF CYTOKINE PRODUCTION/VIRAL REPLICATION ON BODY COMPOSITION
-
批准号:6219451
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:Kathleen Mulligan
-
依托单位:
METABOLIC EFFECTS OF PROTEASE INHIBITORS IN HIV DISEASE
-
批准号:2821935
-
项目类别:
-
资助金额:$17.5万
-
财政年份:1998
-
负责人:Kathleen Mulligan
-
依托单位:
METABOLIC EFFECTS OF PROTEASE INHIBITORS IN HIV DISEASE
-
批准号:6017794
-
项目类别:
-
资助金额:$17.27万
-
财政年份:1998
-
负责人:Kathleen Mulligan
-
依托单位:
NANDROLONE IN HIV ASSOCIATED WEIGHT LOSS
-
批准号:6115455
-
项目类别:
-
资助金额:$3.1万
-
财政年份:1998
-
负责人:Kathleen Mulligan
-
依托单位:
INHIBITION OF CYTOKINE PRODUCTION/VIRAL REPLICATION ON BODY COMPOSITION
-
批准号:6115464
-
项目类别:
-
资助金额:$3.1万
-
财政年份:1998
-
负责人:Kathleen Mulligan
-
依托单位:
METABOLIC EFFECTS OF PROTEASE INHIBITORS IN HIV DISEASE
-
批准号:6177818
-
项目类别:
-
资助金额:$40.19万
-
财政年份:1998
-
负责人:Kathleen Mulligan
-
依托单位:
METABOLIC EFFECTS OF PROTEASE INHIBITORS IN HIV DISEASE
-
批准号:2906308
-
项目类别:
-
资助金额:$40.2万
-
财政年份:1998
-
负责人:Kathleen Mulligan
-
依托单位:
NANDROLONE IN HIV ASSOCIATED WEIGHT LOSS
-
批准号:6219442
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:Kathleen Mulligan
-
依托单位:
海外基金